Breast/ovarian cancer
51 – 60 of 111
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Regulatory T lymphocyte infiltration in metastatic breast cancer—an independent prognostic factor that changes with tumor progression
(
- Contribution to journal › Article
-
Mark
Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity
(
- Contribution to journal › Article
-
Mark
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer
(
- Contribution to journal › Article
-
Mark
Protein signature predicts response to neoadjuvant treatment with chemotherapy and bevacizumab in HER2-negative breast cancers
(
- Contribution to journal › Article
-
Mark
Evaluation of multiple transcriptomic gene risk signatures in male breast cancer
(
- Contribution to journal › Article
-
Mark
Homologous recombination repair mechanisms in serous endometrial cancer
(
- Contribution to journal › Article
-
Mark
Common Susceptibility Loci for Male Breast Cancer
(
- Contribution to journal › Article
-
Mark
Breast cancer risk genes - Association analysis in more than 113,000 women
(
- Contribution to journal › Article
-
Mark
Detection of Copy Number Aberration and Tumor Fraction in Archival Cervical Specimens from Ovarian Cancer Patients using Shallow Whole Genome Sequencing.
2021)(
- Contribution to conference › Poster
-
Mark
PD-L1 Testing in Cytological Non-Small Cell Lung Cancer Specimens : A Comparison with Biopsies and Review of the Literature
(
- Contribution to journal › Article